Elite in Osteosarcoma
Elite in Osteosarcoma
5323 Harry Hines Blvd, 
Dallas, TX 

Overview

Patrick Leavey is a Pediatric Hematologist Oncology provider in Dallas, Texas. Dr. Leavey is rated as an Elite provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Osteosarcoma, Ewing Sarcoma, Adult Soft Tissue Sarcoma, Hepatoblastoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 54 peer reviewed articles and participating in 30 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 23 articles and participated in 18 clinical trials in the study of Osteosarcoma.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

5323 Harry Hines Blvd, Dallas, TX 75390

Additional Areas of Focus

Dr. Leavey has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


30 Clinical Trials

Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Evolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Study of DS-8201a (NSC# 807708) in Adolescents, or Young Adults With Recurrent HER2+ Osteosarcoma
A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma
Key Adverse Events After Childhood Cancer
View 29 Less Clinical Trials
Similar Doctors
Distinguished in Osteosarcoma
Pediatric Hematology Oncology
Distinguished in Osteosarcoma
Pediatric Hematology Oncology
1935 Medical District Dr, 
Dallas, TX 
 (0.2 miles away)
Languages Spoken:
English

James Amatruda is a Pediatric Hematologist Oncology provider in Dallas, Texas. Dr. Amatruda is rated as a Distinguished provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Germ Cell Tumor, Teratoma of the Mediastinum, Ewing Sarcoma, Osteosarcoma, and Orchiectomy.

Advanced in Osteosarcoma
Pediatric Hematology Oncology
Advanced in Osteosarcoma
Pediatric Hematology Oncology
1935 Medical District Dr, Graduate Medical Education, 
Dallas, TX 
 (0.2 miles away)
Languages Spoken:
English

John Ligon is a Pediatric Hematologist Oncology provider in Dallas, Texas. Dr. Ligon is rated as an Advanced provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Osteosarcoma, Adult Soft Tissue Sarcoma, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Bone Marrow Transplant.

Advanced in Osteosarcoma
Pediatric Hematology Oncology
Advanced in Osteosarcoma
Pediatric Hematology Oncology
1935 Medical District Dr, 
Dallas, TX 
 (0.2 miles away)
Languages Spoken:
English

Matthew Campbell is a Pediatric Hematologist Oncology provider in Dallas, Texas. Dr. Campbell is rated as an Advanced provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Febrile Neutropenia, Acute Lymphoblastic Leukemia (ALL), Osteosarcoma, and Ewing Sarcoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leavey's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile